Skip to content
Secretin synthetic human
Chirhostim (secretin synthetic human) is a protein pharmaceutical. Secretin synthetic human was first approved as Secretin-ferring on 1982-01-01. The pharmaceutical is active against secretin receptor.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Chirhostim
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Secretin
Tradename
Company
Number
Date
Products
SECRETIN-FERRINGFerring PharmaceuticalsN-018290 DISCN1982-01-01
1 products
Hide discontinued
Secretin synthetic human
Tradename
Company
Number
Date
Products
CHIRHOSTIMChiRhoClinN-021256 RX2004-04-09
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
chirhostim chirhostim 40New Drug Application2021-10-14
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V04: Diagnostic agents
— V04C: Other diagnostic agents in atc
— V04CK: Pancreatic function test diagnostic agents
— V04CK01: Secretin
HCPCS
No data
Clinical
Clinical Trials
34 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PancreatitisD010195EFO_0000278K85111115
Sphincter of oddi dysfunctionD046628———1—1
Diabetes mellitusD003920EFO_0000400E08-E13———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic neoplasmsD010190EFO_0003860C25211—69
Autistic disorderD001321EFO_0003758F84.0——3——3
ObesityD009765EFO_0001073E66.9—11—12
Peutz-jeghers syndromeD010580Q85.89——1—12
Irritable bowel syndromeD043183EFO_0000555K58——1——1
Abdominal painD015746R10.9——1——1
Hereditary nonpolyposis colorectal neoplasmsD003123EFO_0007354——1——1
Pancreatic diseasesD010182K86.9——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic pancreatitisD050500EFO_0000342K86.152———5
Healthy volunteers/patients—11——12
DyspepsiaD004415EFO_0008533K3011———1
SchizophreniaD012559EFO_0000692F20—1———1
Obsessive-compulsive disorderD009771EFO_0004242F42—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic intraductal neoplasmsD0000777791———12
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Metabolic syndromeD024821EFO_0000195E88.81————11
AdiposityD050154————11
Endoscopic retrograde cholangiopancreatographyD002760————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSECRETIN SYNTHETIC HUMAN
INN—
Description
Secretin precursor
Classification
Protein
Drug classretinol derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID108153-74-8
RxCUI—
ChEMBL IDCHEMBL1201488
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
Agency Approved
SCTR
SCTR
Organism
Homo sapiens
Gene name
SCTR
Gene synonyms
NCBI Gene ID
6344
Protein name
secretin receptor
Protein synonyms
pancreatic secretin receptor
Uniprot ID
Q53T00
Mouse ortholog
Sctr (319229)
secretin receptor (Q5FWI2)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 35 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details